Kelly Ganjei, AmplifyBio CEO
October 3, 2022 06:18 AM EDTUpdated 04:33 PM
Deals
Cell/Gene Tx
Manufacturing

Am­pli­fy­Bio scoops up lab space and oth­er as­sets from PACT Phar­ma as cell ther­a­py biotech read­justs

Tyler Patchen

News Reporter

The West Coast cell ther­a­py biotech PACT Phar­ma was fac­ing some chal­lenges af­ter sev­er­al em­ploy­ees got the axe from the com­pa­ny and ex­ecs put …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK leaves biotech trade group BIO

Biotech in­dus­try wor­ries over po­ten­tial for RFK Jr. al­ly as FDA pick

Benev­o­len­tAI’s co-founder is back. Here’s how he plans a turn­around at the AI com­pa­ny dur­ing a ‘piv­otal time’

Charles Riv­er to close ‘15 small­er sites’ as de­mand for ear­ly re­search de­clines

Ei­sai slash­es Leqem­bi sales fore­cast by al­most $100M

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times